Secondly, tak242 specifically blocks TIR Toll/IL- 1 receptor in the intracellular domain of TLR4, without affecting the extracellular docking with its main ligand LPS. Therefore, TAK-242 inhibits the intracellular signal transduction of TLR-4 and prevents it from binding to its adapter molecules.
Personally, I think TAK-242 may be more useful.